Analyst Consensus ?
ConsensusHold39 ratings
Bullish1846.1%
Neutral1743.6%
Bearish410.3%
FN2 Earnings Intelligence
LyondellBasell Industries N.V. analyst ratings
LyondellBasell Industries N.V. (LYB) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$60.44Current
$43Low
$88.69Average
$146High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 20, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 6, 2026 |
| Alembic Global | Overweight | Overweight | Maintain | Jul 2, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 1, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jun 30, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| UBS | Neutral | Neutral | Maintain | Jun 5, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | May 28, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | May 4, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 4, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 19, 2026 |
| Jefferies | Hold | Hold | Maintain | Mar 10, 2026 |
| Fermium Research | Buy | Hold | Upgrade | Mar 9, 2026 |
| Keybanc | Overweight | Sector Weight | Upgrade | Mar 4, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Nov 11, 2025 |
| Goldman Sachs | Sell | Sell | Maintain | Oct 17, 2025 |
| Piper Sandler | Neutral | Neutral | Maintain | May 1, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 1, 2025 |
| Vertical Research | Buy | Hold | Upgrade | Jan 3, 2024 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Jan 31, 2023 |
| HSBC | Buy | Hold | Upgrade | Dec 10, 2021 |
| Argus Research | Buy | Hold | Upgrade | Feb 2, 2021 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Jan 6, 2021 |
| Bernstein | Market Perform | Outperform | Downgrade | Nov 13, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 6, 2020 |
| ScotiaBank | Sector Perform | Sector Outperform | Downgrade | May 4, 2020 |
| CFRA | Strong Buy | Strong Buy | Maintain | Jan 31, 2020 |
| Nomura | Neutral | Neutral | Maintain | Sep 18, 2019 |
| Bank of America | Buy | Buy | Maintain | Aug 5, 2019 |
| Standpoint Research | Buy | Hold | Upgrade | Oct 12, 2018 |
| Susquehanna | Neutral | Positive | Downgrade | Feb 10, 2017 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Jun 13, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Jan 11, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Oct 12, 2015 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 27, 2014 |
| Imperial Capital | Buy | Buy | Maintain | Jul 29, 2013 |
| Dahlman Rose | Buy | Buy | Maintain | Jan 9, 2013 |
| PiperJaffray | Neutral | Neutral | Maintain | Oct 29, 2012 |
| Bank oferica | Buy | Buy | Maintain | Apr 4, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $60.44. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $72 | $59.32 | +19.1% | Jul 20, 2026 |
| Goldman Sachs | Analyst unavailable | $62 | $58.67 | +2.6% | Jul 16, 2026 |
| BMO Capital | Analyst unavailable | $64 | $53.36 | +5.9% | Jul 6, 2026 |
| Wells Fargo | Abigail Eberts | $70 | $53.36 | +15.8% | Jul 3, 2026 |
| Alembic Global | Analyst unavailable | $83 | $52.58 | +37.3% | Jul 2, 2026 |
| Mizuho Securities | Analyst unavailable | $62 | $52.65 | +2.6% | Jul 1, 2026 |
| UBS | Analyst unavailable | $73 | $65.65 | +20.8% | Jun 5, 2026 |
| Wells Fargo | Analyst unavailable | $98 | $67.67 | +62.1% | May 28, 2026 |
| BMO Capital | John McNulty | $88 | $77.25 | +45.6% | May 5, 2026 |
| UBS | Analyst unavailable | $82 | $77 | +35.7% | May 5, 2026 |
| Wells Fargo | Michael Sison | $80 | $76.04 | +32.4% | May 5, 2026 |
| Morgan Stanley | Vincent Andrews | $77 | $69.32 | +27.4% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $91 | $74.23 | +50.6% | Apr 10, 2026 |
| Alembic Global | Analyst unavailable | $100 | $72.27 | +65.5% | Apr 9, 2026 |
| UBS | Analyst unavailable | $79 | $77.72 | +30.7% | Mar 26, 2026 |
| Wells Fargo | Analyst unavailable | $76 | $67.37 | +25.7% | Mar 12, 2026 |
| Fermium Research | Analyst unavailable | $74 | $66.82 | +22.4% | Mar 9, 2026 |
| Vertical Research | Analyst unavailable | $75 | $66.82 | +24.1% | Mar 9, 2026 |
| RBC Capital | Analyst unavailable | $82 | $66.82 | +35.7% | Mar 9, 2026 |
| RBC Capital | Analyst unavailable | $94 | $59.53 | +55.5% | Mar 4, 2026 |
| KeyBanc | Aleksey Yefremov | $73 | $58.21 | +20.8% | Mar 4, 2026 |
| BMO Capital | Analyst unavailable | $38 | $56.74 | -37.1% | Feb 23, 2026 |
| RBC Capital | Analyst unavailable | $51 | $53.33 | -15.6% | Feb 3, 2026 |
| Mizuho Securities | Analyst unavailable | $53 | $49 | -12.3% | Feb 2, 2026 |
| Wells Fargo | Michael Sison | $48 | $49 | -20.6% | Feb 2, 2026 |
| RBC Capital | Analyst unavailable | $49 | $50.47 | -18.9% | Jan 16, 2026 |
| Vertical Research | Analyst unavailable | $48 | $46.2 | -20.6% | Jan 7, 2026 |
| UBS | Analyst unavailable | $38 | $43.6 | -37.1% | Dec 23, 2025 |
| Wells Fargo | Michael Sison | $45 | $43.06 | -25.5% | Dec 19, 2025 |
| BMO Capital | John McNulty | $36 | $44.4 | -40.4% | Dec 15, 2025 |
| Mizuho Securities | John Roberts | $49 | $45.23 | -18.9% | Dec 11, 2025 |
| Fermium Research | Analyst unavailable | $50 | $46.35 | -17.3% | Dec 3, 2025 |
| UBS | Analyst unavailable | $41 | $46.27 | -32.2% | Nov 4, 2025 |
| Mizuho Securities | John Roberts | $52 | $46.42 | -14.0% | Nov 3, 2025 |
| Goldman Sachs | Analyst unavailable | $51 | $45.86 | -15.6% | Oct 17, 2025 |
| RBC Capital | Analyst unavailable | $50 | $45.16 | -17.3% | Oct 14, 2025 |
| UBS | Joshua Spector | $43 | $48.94 | -28.9% | Oct 6, 2025 |
| Mizuho Securities | Analyst unavailable | $54 | $49.33 | -10.7% | Oct 3, 2025 |
| UBS | Joshua Spector | $49 | $64.28 | -18.9% | Jul 9, 2025 |
| Fermium Research | Analyst unavailable | $70 | $59.44 | +15.8% | Apr 25, 2025 |
| Alembic Global | Hassan Ahmed | $67 | $58.76 | +10.9% | Apr 25, 2025 |
| UBS | Joshua Spector | $51 | $56.44 | -15.6% | Apr 7, 2025 |
| Wells Fargo | Michael Sison | $85 | $57.98 | +40.6% | Apr 4, 2025 |
| Deutsche Bank | David Begleiter | $80 | $72.48 | +32.4% | Jan 10, 2025 |
| BMO Capital | John McNulty | $98 | $85.12 | +62.1% | Nov 11, 2024 |
| Piper Sandler | Charles Neivert | $112 | $85.3 | +85.3% | Nov 8, 2024 |
| Wolfe Research | Chris Parkinson | $91 | $92.44 | +50.6% | Aug 5, 2024 |
| BMO Capital | John McNulty | $105 | $101.7 | +73.7% | Apr 29, 2024 |
| RBC Capital | Arun Viswanathan | $113 | $101.7 | +87.0% | Apr 29, 2024 |
| Piper Sandler | Charles Neivert | $119 | $101.34 | +96.9% | Apr 29, 2024 |
| Barclays | Michael Leithead | $100 | $105.86 | +65.5% | Apr 4, 2024 |
| Wells Fargo | Michael Sison | $117 | $102.07 | +93.6% | Apr 2, 2024 |
| Barclays | Lauren Lieberman | $146 | $93.79 | +141.6% | Oct 4, 2023 |
| Piper Sandler | Charles Neivert | $118 | $95.46 | +95.2% | Apr 11, 2023 |
| Deutsche Bank | Analyst unavailable | $100 | $97.69 | +65.5% | Feb 6, 2023 |
| Wells Fargo | Analyst unavailable | $109 | $98.15 | +80.3% | Feb 6, 2023 |
| UBS | Analyst unavailable | $91 | $91.38 | +50.6% | Jan 11, 2023 |
| Wells Fargo | Analyst unavailable | $97 | $92.06 | +60.5% | Jan 9, 2023 |
| Mizuho Securities | Christopher Parkinson | $88 | $87.15 | +45.6% | Nov 14, 2022 |
| Goldman Sachs | Duffy Fischer | $80 | $77.23 | +32.4% | Oct 13, 2022 |
| UBS | Joshua Spector | $83 | $77.15 | +37.3% | Sep 19, 2022 |
| Deutsche Bank | Analyst unavailable | $85 | $76.69 | +40.6% | Sep 16, 2022 |
| Deutsche Bank | Analyst unavailable | $92 | $80.07 | +52.2% | Sep 14, 2022 |
| Wells Fargo | Analyst unavailable | $100 | $82.45 | +65.5% | Sep 13, 2022 |
| Vertical Research | Kevin McCarthy | $96 | $86 | +58.8% | Aug 8, 2022 |
| Mizuho Securities | Analyst unavailable | $113 | $86.1 | +87.0% | Aug 3, 2022 |
| Deutsche Bank | Analyst unavailable | $95 | $86.2 | +57.2% | Aug 2, 2022 |
| Morgan Stanley | Analyst unavailable | $115 | $84.79 | +90.3% | Aug 2, 2022 |
| RBC Capital | Analyst unavailable | $97 | $86.95 | +60.5% | Aug 2, 2022 |
| Barclays | Analyst unavailable | $102 | $86.95 | +68.8% | Aug 2, 2022 |
| UBS | Analyst unavailable | $93 | $84.08 | +53.9% | Jul 13, 2022 |
| Barclays | Analyst unavailable | $110 | $86.58 | +82.0% | Jul 11, 2022 |
| Credit Suisse | John Roberts | $70 | $87.66 | +15.8% | Jul 5, 2022 |
| Jefferies | Laurence Alexander | $117 | $87.86 | +93.6% | Jun 30, 2022 |
| RBC Capital | Arun Viswanathan | $99 | $87.46 | +63.8% | Jun 30, 2022 |
| J.P. Morgan | Analyst unavailable | $115 | $91.16 | +90.3% | Jun 17, 2022 |
| Mizuho Securities | Analyst unavailable | $132 | $110.58 | +118.4% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $127 | $107.84 | +110.1% | May 2, 2022 |
| Wells Fargo | Analyst unavailable | $125 | $108.81 | +106.8% | May 2, 2022 |
| Barclays | Michael Leithead | $130 | $106.03 | +115.1% | May 2, 2022 |
| Mizuho Securities | Analyst unavailable | $125 | $110.66 | +106.8% | Apr 19, 2022 |
| Wells Fargo | Michael Sison | $120 | $107.58 | +98.5% | Apr 16, 2022 |
| Deutsche Bank | David Begleiter | $104 | $95.63 | +72.1% | Jan 30, 2022 |
| Wells Fargo | Michael Sison | $115 | $95.63 | +90.3% | Jan 30, 2022 |
| Atlantic Equities | Colin Isaac | $113 | $99.84 | +87.0% | Jan 18, 2022 |
| HSBC | Sriharsha Pappu | $112 | $88.89 | +85.3% | Dec 10, 2021 |
| Wolfe Research | Josh Silverstein | $132 | $108.19 | +118.4% | Jun 9, 2021 |
| Barclays | Duffy Fischer | $125 | $102.52 | +106.8% | Apr 19, 2021 |
Track every rating change on LYB the moment it posts. Free to start.
Start free